| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/01/2004 | US20040127491 For therapy of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases |
| 07/01/2004 | US20040127484 Novel bicyclic inhibitors of hormone sensitive lipase |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127481 Administering a therapeutic amount of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride condensation aerosol |
| 07/01/2004 | US20040126701 Fluorescent dye and structure and manufacturing method of fluorescent storage media using thereof |
| 07/01/2004 | US20040126329 Delivery of analgesics through an inhalation route |
| 07/01/2004 | US20040126328 Arerosol; heating drug, vaporization, cooling |
| 07/01/2004 | US20040126327 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 07/01/2004 | US20040126326 Delivery of antidepressants through an inhalation route |
| 07/01/2004 | DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments |
| 07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 07/01/2004 | CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists |
| 07/01/2004 | CA2509665A1 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | CA2509249A1 Method of making tricyclic aminocyanopyridine compounds |
| 07/01/2004 | CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | CA2509214A1 Indolizine compounds |
| 07/01/2004 | CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 07/01/2004 | CA2505405A1 [1,7]naphthyridines as pde4 inhibitors |
| 06/30/2004 | EP1433789A1 Pyrrolopyrazines and their use as selective apoptosis inducers |
| 06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
| 06/30/2004 | EP1432713A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 06/30/2004 | EP1432712A1 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 06/30/2004 | EP1432711A1 1,6-naphthyridine derivatives as antidiabetics |
| 06/30/2004 | EP1432710A1 1, 8-naphthyridine derivatives as antidiabetics |
| 06/30/2004 | EP1432709A1 1-glyoxlylamide indolizines for treating cancer |
| 06/30/2004 | EP1432708A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity |
| 06/30/2004 | EP1432707A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/30/2004 | EP1432705A2 Dual action antibiotics |
| 06/30/2004 | EP1432704A1 Synthesis of key azole-antifungal intermediates |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432693A2 Mch receptor antagonists |
| 06/30/2004 | EP1432692A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 06/30/2004 | EP1244611B1 Squaric acid derivatives as integrin antagonists |
| 06/30/2004 | EP1206281B1 Formulation containing moxifloxacin and sodium chloride |
| 06/30/2004 | EP1150985B1 A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes |
| 06/30/2004 | CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509172A Pirenzepine ophthalmic gel |
| 06/30/2004 | CN1509170A Method for inhibiting adhesion formation |
| 06/30/2004 | CN1509140A Pyridinyl fused bicyclic amide as fungicides |
| 06/30/2004 | CN1508136A Tetrahydropyrido compound |
| 06/30/2004 | CN1155598C Tetrahydropyridoethers |
| 06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
| 06/30/2004 | CN1155312C Herbicidal synergic composition and method for controlling weed |
| 06/30/2004 | CN1155311C Herbicidal synergic composition and method for controlling weed |
| 06/29/2004 | US6756498 Process for the preparation of chemical compounds |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756383 Such as 3-(2-(methoxycarbonyl)acetylamino)pyridine-4-carboxylic acid for treatment of diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases; enzyme inhibitors |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
| 06/24/2004 | WO2004052891A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors |
| 06/24/2004 | WO2004052890A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | WO2004052889A1 Compounds as radioligands for the diagnosis of disease |
| 06/24/2004 | WO2004052882A1 Process for preparing optically pure active compounds |
| 06/24/2004 | WO2004052866A1 3-phenyl-cinnoline homologue and antitumor agent containing the same |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052861A1 Hydroxyalkylated cyclic diamine compound |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052291A2 Pyridines for treating injured mammalian nerve tissue |
| 06/24/2004 | WO2004052288A2 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | WO2004035576A3 Pre-organized tricyclic integrase inhibitor compounds |
| 06/24/2004 | WO2004017922A3 Keto cannabinoids with therapeutic indications |
| 06/24/2004 | WO2004011425A3 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122231 Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
| 06/24/2004 | US20040122230 Opiate analogs selective for the delta -opioid receptor |
| 06/24/2004 | US20040122218 Pyrrolopyridine potassium channel openers |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040122046 NPY-5 antagonists |
| 06/24/2004 | US20040122044 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations |
| 06/24/2004 | US20040122043 Imidazopyridine compounds as 5-HT4 receptor agonists |
| 06/24/2004 | US20040122039 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 06/24/2004 | US20040122036 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122029 6-(4-Methoxy-phenyl)-8-phenyl-2-phenylamino-5,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one for example; anticancer agents; chemical intermediates |
| 06/24/2004 | US20040122027 Use of pyridoindolone derivatives for preparing anticancer medicines |
| 06/24/2004 | US20040121999 for treatment of physiological conditions/disorders arising from the hypersecretion of corticotropin-releasing factor (CRF) such as depression, anxiety, and substance abuse |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |
| 06/24/2004 | DE10256264A1 New trisubstituted dihydro-imidazo-pyridazinone or imidazo-pyridinone derivatives, useful as dipeptidylpeptidase-IV inhibitors for e.g. treating diabetes mellitus type I or II, arthritis or obesity |
| 06/24/2004 | DE10233955A1 Preparation of quaterylene-bisimides, useful as fluorescent dyes, e.g. for natural or synthetic textiles or as markers for biomolecules, by base cyclization of a bis-perylene-dicarboxylic acid imide |
| 06/24/2004 | CA2508792A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | CA2508165A1 Pyridines for treating injured mammalian nerve tissue |
| 06/24/2004 | CA2508147A1 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | CA2508010A1 3-phenyl-cinnoline analogue and antitumor agent using the same |
| 06/24/2004 | CA2507807A1 Process for preparing optically pure proton pump inhibitors |